GLP-1 Drugs Could Help Narrow Lifespan Gap in Serious Mental Illness
Adults with serious mental illness (SMI) have a shorter lifespan than the general population, primarily driven by cardiovascular disease. GLP-1 initiators had a 24% lower 4-year mortality risk than SGLT2…
